Edwards Lifesciences Prosthetic Valve Delivery Patent Granted

The USPTO issued patent US12588991B2 to Edwards Lifesciences Corporation on March 31, 2026, covering a prosthetic valve delivery apparatus with an indicator arm mechanism. The indicator arm maintains a first configuration when the prosthetic valve diameter is below a first predetermined size and changes to a second configuration when the valve expands to that predetermined diameter, providing visual confirmation of expansion status. The patent application (No. 17888348) was filed August 15, 2022, and contains 18 claims.

Patent holders should review the granted claims to assess freedom-to-operate implications for competing prosthetic valve delivery systems. Competitors developing similar indicator mechanisms may need to design around this patent or evaluate licensing options. This grant strengthens Edwards Lifesciences' intellectual property position in the transcatheter aortic valve replacement (TAVR) space but does not impose compliance obligations on other market participants.